Effect of Zinc Supplementation on Appetite and Growth in Primary Malnourished Children

NCT ID: NCT03098810

Last Updated: 2017-04-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-04-01

Study Completion Date

2017-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Zinc supplementation effect on appetite and growth of malnourished children

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators will do s. Zinc and letting before and after zinc supplementation

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Appetite Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Normal children

Placebo

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type OTHER

Oral syrup placebo

Malnourished children

Oral zinc sulphate syrup

Group Type EXPERIMENTAL

Zinc sulphate

Intervention Type DRUG

Oral syrup zinc sulphate

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Zinc sulphate

Oral syrup zinc sulphate

Intervention Type DRUG

Placebo

Oral syrup placebo

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* primary malnourished

Exclusion Criteria

* zinc supplementation in the previous 3 months Children with chronic disease
Minimum Eligible Age

2 Years

Maximum Eligible Age

10 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ain Shams University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marian girgis

Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marian Girgis

Role: PRINCIPAL_INVESTIGATOR

Ain Shams University

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marian Girgis

Role: CONTACT

0201223646224

References

Explore related publications, articles, or registry entries linked to this study.

Imdad A, Rogner J, Sherwani RN, Sidhu J, Regan A, Haykal MR, Tsistinas O, Smith A, Chan XHS, Mayo-Wilson E, Bhutta ZA. Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years. Cochrane Database Syst Rev. 2023 Mar 30;3(3):CD009384. doi: 10.1002/14651858.CD009384.pub3.

Reference Type DERIVED
PMID: 36994923 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2272009

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Zinc Supplementation in Shigella Patients
NCT00321126 COMPLETED PHASE3
Therapeutic Zinc in Childhood Pneumonia
NCT00252304 COMPLETED PHASE2/PHASE3
Zinc Sulfate Acceptability
NCT04039828 COMPLETED NA
Zinc Resistant Starch Project
NCT01811836 COMPLETED NA